Karo Pharma AB - Strategy, SWOT and Corporate Finance Report

Karo Pharma AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Karo Pharma AB (Karo Pharma), formerly Karo Bio AB, is a health care company that focuses on research and development of pharmaceutical products in the areas of cancer and autoimmune diseases. Its key research area involves nuclear receptors as target proteins for the development of new pharmaceuticals. Karo Pharma discovers drugs to target major diseases including autoimmune diseases such as multiple sclerosis; and multiple types of cancer, viral and bacterial infections. The company’s projects are based on ROR gamma receptor and estrogen receptor. Its development pipeline also includes T268A Cold Spray which utilizes glucose oxidase enzyme in combination with glucose to fight against cold virus. Karo Pharma is headquartered in Huddinge, Stockholm, Sweden.

Scope

  • Detailed information on Karo Pharma AB required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Karo Pharma AB in the form of a SWOT analysis
  • An in-depth view of the business model of Karo Pharma AB including a breakdown and examination of key business segments
  • News about Karo Pharma AB, such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

  • Gain understanding of Karo Pharma AB and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Karo Pharma AB as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Karo Pharma ABs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Active Biotech AB

Nuevolution AB

Genmab A/S

BioInvent International AB

Meda AB

Dyax Corp

Active Biotech AB

Nuevolution AB

Genmab A/S

BioInvent International AB

Meda AB

Dyax Corp

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Karo Pharma AB ...

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1 - About the Company 6

Karo Pharma AB - Key Facts 6

Karo Pharma AB - Key Employees 7

Karo Pharma AB - Key Employee Biographies 8

Karo Pharma AB - Key Operational Employees 9

Karo Pharma AB - Major Products and Services 10

Karo Pharma AB - History 11

Karo Pharma AB - Company Statement 14

Karo Pharma AB - Locations And Subsidiaries 15

Head Office 15

Other Locations & Subsidiaries 15

Section 2 – Company Analysis 16

Company Overview 16

Karo Pharma AB - Business Description 17

R&D Overview 17

Karo Pharma AB - Corporate Strategy 18

Karo Pharma AB - SWOT Analysis 19

SWOT Analysis - Overview 19

Karo Pharma AB - Strengths 19

Karo Pharma AB - Weaknesses 20

Karo Pharma AB - Opportunities 21

Karo Pharma AB - Threats 22

Karo Pharma AB - Key Competitors 23

Section 3 – Company Financial Ratios 24

Financial Ratios - Capital Market Ratios 24

Financial Ratios - Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios - Interim Ratios 29

Financial Ratios - Ratio Charts 30

Section 4 – Company’s Lifesciences Financial Deals and Alliances 31

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Karo Pharma AB, Recent Deals Summary 33

Section 5 – Company’s Recent Developments 34

Apr 26, 2018: Karo Pharma Doubles Sales and Earnings in the First Quarter 34

Mar 23, 2018: Karo Pharma Supports Operation Smile 35

Mar 01, 2018: LEO Pharma sells portfolio of 10 products to Karo Pharma 36

Feb 22, 2018: Karo Pharma: Year-end Report 2017 37

Nov 02, 2017: Karo Pharma: Interim Report January– September 2017 38

Aug 24, 2017: Karo Pharma: Interim Report January–June 2017 40

May 10, 2017: Karo Pharma: interim report January - March-2017 41

Feb 28, 2017: Karo Pharma: Full Year Report 2016 42

Section 6 – Appendix 43

Methodology 43

Ratio Definitions 43

About GlobalData 47

Contact Us 47

Disclaimer 47

List of Tables

List of Tables

Karo Pharma AB, Key Facts 6

Karo Pharma AB, Key Employees 7

Karo Pharma AB, Key Employee Biographies 8

Karo Pharma AB, ...

List of Tables

Karo Pharma AB, Key Facts 6

Karo Pharma AB, Key Employees 7

Karo Pharma AB, Key Employee Biographies 8

Karo Pharma AB, Key Operational Employees 9

Karo Pharma AB, Major Products and Services 10

Karo Pharma AB, History 11

Karo Pharma AB, Subsidiaries 15

Karo Pharma AB, Key Competitors 23

Karo Pharma AB, Ratios based on current share price 24

Karo Pharma AB, Annual Ratios 25

Karo Pharma AB, Annual Ratios (Cont...1) 26

Karo Pharma AB, Annual Ratios (Cont...2) 27

Karo Pharma AB, Interim Ratios 29

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 32

Karo Pharma AB, Recent Deals Summary 33

Currency Codes 43

Capital Market Ratios 43

Equity Ratios 44

Profitability Ratios 44

Cost Ratios 45

Liquidity Ratios 45

Leverage Ratios 46

Efficiency Ratios 46

List of Figures

List of Figures

Karo Pharma AB, Performance Chart (2013 - 2017) 28

Karo Pharma AB, Ratio Charts 30

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals ...

List of Figures

Karo Pharma AB, Performance Chart (2013 - 2017) 28

Karo Pharma AB, Ratio Charts 30

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 31

Karo Pharma AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 32

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports